CPH.AX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 Jun 2023 @ 02:10):

Stats
Today's Volume	919 691
Average Volume	10.01M
Market Cap	23.11M
EPS	$0 ( 2024-01-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.450
ATR14	$0.00200 (22.22%)

Volume Correlation

Long: 0.14 (neutral)

Short: 0.55 (weak)

Signal:(39.869) Neutral

Creso Pharma Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Creso Pharma Ltd Correlation - Currency/Commodity

0.47
( neutral )

0.52
( weak )

0.00
( neutral )

-0.27
( neutral )

Creso Pharma Ltd Financials

Annual	2022
Revenue:	$8.69M
Gross Profit:	$287 000 (3.30 %)
EPS:	$-0.0224

Q2	2019
Revenue:	$906 607
Gross Profit:	$531 473 (58.62 %)
EPS:	$-0.0262

Q1	2019
Revenue:	$906 607
Gross Profit:	$531 473 (58.62 %)
EPS:	$-0.0262

Q1	2019
Revenue:	$906 607
Gross Profit:	$531 473 (58.62 %)
EPS:	$-0.0262

Financial Reports:

No articles found.

Creso Pharma Ltd

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.